An analysis of the attrition of drug candidates from four major pharmaceutical companies
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An analysis of the attrition of drug candidates from four major pharmaceutical companies
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 14, Issue 7, Pages 475-486
Publisher
Springer Nature
Online
2015-06-20
DOI
10.1038/nrd4609
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical development success rates for investigational drugs
- (2014) Michael Hay et al. NATURE BIOTECHNOLOGY
- Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
- (2014) David Cook et al. NATURE REVIEWS DRUG DISCOVERY
- Inflation of correlation in the pursuit of drug-likeness
- (2013) Peter W. Kenny et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Improving the Odds of Success in Drug Discovery: Choosing the Best Compounds for in Vivo Toxicology Studies
- (2013) Travis T. Wager et al. JOURNAL OF MEDICINAL CHEMISTRY
- A critical assessment of modeling safety-related drug attrition
- (2013) Daniel Muthas et al. MedChemComm
- Relating Molecular Properties and in Vitro Assay Results to in Vivo Drug Disposition and Toxicity Outcomes
- (2012) Jeffrey J. Sutherland et al. JOURNAL OF MEDICINAL CHEMISTRY
- Reducing safety-related drug attrition: the use of in vitro pharmacological profiling
- (2012) Joanne Bowes et al. NATURE REVIEWS DRUG DISCOVERY
- Strategies to improve in vivo toxicology outcomes for basic candidate drug molecules
- (2011) Tim Luker et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival
- (2011) Paul Morgan et al. DRUG DISCOVERY TODAY
- Getting pharmaceutical R&D back on target
- (2011) Mark E Bunnage Nature Chemical Biology
- The influence of the 'organizational factor' on compound quality in drug discovery
- (2011) Paul D. Leeson et al. NATURE REVIEWS DRUG DISCOVERY
- Probing the links between in vitro potency, ADMET and physicochemical parameters
- (2011) M. Paul Gleeson et al. NATURE REVIEWS DRUG DISCOVERY
- Lipophilicity in drug discovery
- (2010) Michael J Waring Expert Opinion on Drug Discovery
- Defining optimum lipophilicity and molecular weight ranges for drug candidates—Molecular weight dependent lower logD limits based on permeability
- (2009) Michael J. Waring BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Pharmacological Promiscuity: Dependence on Compound Properties and Target Specificity in a Set of Recent Roche Compounds
- (2009) Jens-Uwe Peters et al. ChemMedChem
- Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
- (2009) Frank Lovering et al. JOURNAL OF MEDICINAL CHEMISTRY
- Accurate In Silico log PPredictions: One Can't Embrace the Unembraceable
- (2009) Igor V. Tetko et al. Quantitative structure-activity relationships & combinatorial science
- Physiochemical drug properties associated with in vivo toxicological outcomes
- (2008) Jason D. Hughes et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Generation of a Set of Simple, Interpretable ADMET Rules of Thumb
- (2008) M. Paul Gleeson JOURNAL OF MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now